Drug Interactions between Bexxar and Iodotope
This report displays the potential drug interactions for the following 2 drugs:
- Bexxar (iodine i 131 tositumomab)
- Iodotope (sodium iodide-i-131)
Interactions between your drugs
No interactions were found between Bexxar and Iodotope. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Bexxar
A total of 281 drugs are known to interact with Bexxar.
- Bexxar is in the following drug classes: CD20 monoclonal antibodies, therapeutic radiopharmaceuticals.
- Bexxar is used to treat Non-Hodgkin's Lymphoma.
Iodotope
A total of 165 drugs are known to interact with Iodotope.
- Iodotope is in the following drug classes: antithyroid agents, therapeutic radiopharmaceuticals.
- Iodotope is used to treat the following conditions:
Drug and food interactions
sodium iodide I-131 food
Applies to: Iodotope (sodium iodide-i-131)
MONITOR: Excessive intake of dietary iodine (e.g., iodised salt) may interfere with adequate uptake of radioiodide by the thyroid .
MANAGEMENT: A diet low in iodine is recommended before initiating therapy with sodium iodide I-131 or I-123.
References
- Cerner Multum, Inc. "Australian Product Information."
sodium iodide I-131 food
Applies to: Iodotope (sodium iodide-i-131)
ADJUST DOSING INTERVAL: Certain drugs may affect the pharmacokinetics, pharmacodynamics, and/or diagnostic results of radioiodides.
MANAGEMENT: Antithyroid agents such as carbimazole or propylthiouracil should generally be withheld for 1 week before administration of sodium iodide I-131 or I-123, and for a few days afterward. Salicylates, steroids, anticoagulants, antihistamines, antiparasitics, penicillins, sulfonamides, tolbutamide, thiopental, and nitroprusside should generally be withheld for 1 week. Amiodarone, lithium, and benzodiazepines should be withheld for at least 4 weeks.
References
- (2022) "Product Information. Sodium Iodide I-123 (sodium iodide I-123)." GE Healthcare
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Radiopharmaceutical agents
Therapeutic duplication
The recommended maximum number of medicines in the 'radiopharmaceutical agents' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'radiopharmaceutical agents' category:
- Bexxar (iodine i 131 tositumomab)
- Iodotope (sodium iodide-i-131)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.